Epigenetic Reprogramming May Significantly Enhance Immunotherapy Efficacy

News   Jul 03, 2017 | Original story from St. Jude Children’s Research Hospital

 
Epigenetic Reprogramming May Significantly Enhance Immunotherapy Efficacy

(from left) Corresponding author Benjamin Youngblood, Ph.D., is with first author Hazem Ghoneim, Ph.D. Credit: St. Jude Children’s Research Hospital

 
 
 
 

RELATED ARTICLES

Freedom of Information Request Reveals Benefits of Blocked MS Drug

News

A drug that is blocked by the EU regulatory system has now been found to improve the quality of life of people with multiple sclerosis (MS), according to a study by Queen Mary University of London (QMUL).

READ MORE

Test Successfully Identifies Which Research Results in Mice Will Help Humans With MS

News

In determining which genes are conserved across species, the researchers also discovered a new gene that improves myelin repair.

READ MORE

Are Stem Cells the Link Between Bacteria and Cancer?

News

New mechanism of stomach gland regeneration reveals impact of Helicobacter pylori infection.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE